Lisa Delfini
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Lisa Delfini
Earlier roles on record: CFO at Trevi Therapeutics, Inc. (TRVI) until August 22, 2025. Trevi Therapeutics, Inc. reported in an 8-K filed August 20, 2025 that Lisa Delfini resigned as Chief Financial Officer, effective August 22, 2025. The proxy statement of Trevi Therapeutics, Inc. reports total compensation of $1,187,403 for Lisa Delfini in fiscal 2024, including a base salary of $412,169. Disclosed compensation is on record for 2 fiscal years. Lisa Delfini has spoken on 15 earnings calls across 1 company, most recently for Trevi Therapeutics, Inc. on August 7, 2025.
“On August 14, 2025, Trevi Therapeutics, Inc. (the “Company”) and Lisa Delfini, the Company’s Chief Financial Officer, agreed that her employment with the Company would end on August 22, 2025 (the “Effective Date”) and that she would resign as Chief Financial Officer.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2025-08-22
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Trevi Therapeutics, Inc. (TRVI) | Chief Financial Officer | $412,169 | $1,187,403 |
| 2023 | Trevi Therapeutics, Inc. (TRVI) | Chief Financial Officer | — | — |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.